4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Illumina, Inc. (ILMN) operates in the Diagnostics & Research industry and is headquartered in San Diego, United States with about 8,600 employees. Its market capitalization is roughly $29 billion. In the fiscal year ended 2025-12-31, ILMN reported $4.3B in revenue and $850M in net income.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Interactive charts & full statements → Open the ILMN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $4.3B | $4.4B | $4.5B | $4.6B | — |
| Gross Profit | $2.9B | $2.9B | $2.7B | $3.0B | — |
| Operating Income (EBIT) | $817M | $600M | ($222M) | $354M | — |
| Net Income | $850M | ($1.2B) | ($1.2B) | ($4.4B) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.1B | $1.2B | $1.1B | $1.1B | $1.0B | — |
| Gross Profit | $721M | $759M | $733M | $695M | $683M | — |
| Operating Income (EBIT) | $209M | $211M | $227M | $214M | $164M | — |
| Net Income | $134M | $334M | $150M | $235M | $131M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $6.6B | $6.3B | $10.1B | $12.3B | — |
| Total Liabilities | $3.9B | $3.9B | $4.4B | $5.7B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ILMN viewer.
About TickerBase · Data methodology & sources